Introduction of Peg-Ginase 3750 IU Injection

• Peg-Ginase 3750 IU Injection is used to address numerous forms of blood cancer. It may also be used to treat Hodgkin's disease. It is sometimes given with other medications as part of a combination chemotherapy regimen.

  The most common side effects of Peg-Ginase Injection are allergic reactions, rashes, high blood sugar, diarrhea, and stomach pain. If these symptoms become bothersome or severe, it is important to inform your doctor immediately, as the effects of this medication may be prevented or minimized. Regular blood tests are important to monitor blood cell counts and assess heart, liver, and blood sugar levels.

  Before using Peg-Ginase 3750 IU, it is important to tell your doctor if you have heart disease, liver or kidney problems, or if you are currently taking medication to treat infections. In addition, it is extremely important to disclose any medications you are currently taking, as there may be significant interactions with these medications. This Peg-Ginase Injection is not recommended for use during pregnancy or breastfeeding. Both men and women should use effective contraception during treatment to avoid unwanted pregnancy.

  Peg-Ginase 3750 IU Injection is administered as an injection and should be administered under the close supervision of a healthcare professional. Your doctor will determine the appropriate dose and frequency based on your condition and may need to be adjusted over time. It is important to follow your doctor's instructions for using this medication. It is important to note that incorrect use or exceeding the recommended dose can cause serious side effects. It is important to keep taking this medicine unless your doctor tells you otherwise, even if it takes some time before you notice any significant changes.

Uses of Peg-Ginase 3750 IU Injection

• • Blood cancer (Acute lymphocytic leukaemia)
  • Non-Hodgkin's lymphoma (NHL)
    

Benefits of Peg-Ginase 3750 IU Injection

• Blood cancer (Acute lymphocytic leukemia): Blood cancer, known as leukemia, is a malignancy that affects the blood-forming tissues and impairs the body's immune response to infection. Administration of Peg-Ginase 3750 IU Injection inhibits the proliferation of cancer cells and effectively eradicates them. This {Product_nametwo} has significant potency and toxicity, so a thorough discussion with your doctor regarding its potential risks and benefits is necessary. It is important to avoid alcohol during this treatment and to ensure adequate hydration by drinking plenty of water.

  Non-Hodgkin's lymphoma (NHL): Non-Hodgkin's lymphoma is a type of cancer that begins on your lymphatic system, that is a part of the body's germ-combating immune system. Administration of Peg-Ginase 3750 IU inhibits the proliferation of cancer cells and effectively eradicates them. This medication has significant potency and toxicity, so a thorough discussion with your doctor regarding its potential risks and benefits is necessary. It is important to avoid alcohol during this treatment and to ensure adequate hydration by drinking plenty of water.
  

Side Effects of Peg-Ginase 3750 IU Injection

• ​​​​Like all medicines, Peg-Ginase 3750 IU Injection may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
  

Most Common Side Effects of Peg-Ginase 3750 IU Injection

• • Nausea
  • Vomiting
  • Weakness
  • Loss of appetite
  • Diarrhoea
  • Epigastric pain
  • Swelling over hands/ feet and ankles
  • Injection site reaction ( like pain, redness, swelling)
  • Irritability

Common Side Effects of Peg-Ginase 3750 IU Injection

• • Drowsiness
  • Acute Pancreatitis ( Pain in abdomen, unable to eat, swollen and tender abdomen, Rapid pulse)
  • ​Headache
  • Tiredness
  • Irritability
  • Stomach cramps
  • Weight loss​
    

How to Use Peg-Ginase 3750 IU Injection?

• Peg-Ginase 3750 IU Injection is available in liquid form (injectable) for IM and IV use, which should be administered by a healthcare professional under medical supervision. The dosage and frequency of administration will be determined by your physician based on your medical condition and many other factors. Peg-Ginase 3750 IU Injection should not be self-administered.
  

How Peg-Ginase 3750 IU Injection Works?

• Peg-Ginase 3750 IU Injection belongs to a class of medications called antineoplastic agents. It contains asparaginase an enzyme that interferes with natural processes necessary for cancer cell growth, thereby killing or stopping the growth of cancer cells.
  

Safety Advices Peg-Ginase 3750 IU Injection

Alcohol

Unsafe

Drinking alcohol while taking Peg-Ginase 3750 IU is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.

Pregnancy

Unsafe

The use of Peg-Ginase 3750 IU Injection is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.

Breastfeeding

Unsafe

Breastfeeding while taking Peg-Ginase 3750 IU Injection is not recommended as it may be harmful to the baby. The constituents of Peg-Ginase 3750 IU can potentially pass into breast milk and pose a risk to the baby. If you are currently breastfeeding and using Peg-Ginase Injection, it is important to discuss the potential benefits and risks of continuing to breastfeed with your doctor. Your doctor will be able to advise you on how to ensure the optimum health of both you and your baby.

Driving

Safe

It is uncommon for Peg-Ginase 3750 IU Injection to affect your driving skills.

Liver

Use with Caution

For patients with mild liver disease, Peg-Ginase 3750 IU Injection is recommended. No dose adjustment is required in patients with mild liver impairment. However, Peg-Ginase 3750 IU is not recommended for use in patients with moderate or severe liver disease.

Kidney

Use with Caution

For patients with kidney impairment, dose adjustment is not recommended. Peg-Ginase 3750 IU Injection has not been studied in patients with severe renal impairment or in patients who are undergoing peritoneal dialysis or haemodialysis.